Suppr超能文献

在湿热环境中进行运动时,急性摄入对乙酰氨基酚不会改变核心体温或出汗情况。

Acute acetaminophen ingestion does not alter core temperature or sweating during exercise in hot-humid conditions.

作者信息

Coombs G B, Cramer M N, Ravanelli N M, Morris N B, Jay O

机构信息

School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada.

出版信息

Scand J Med Sci Sports. 2015 Jun;25 Suppl 1:96-103. doi: 10.1111/sms.12336.

Abstract

Acute acetaminophen (ACT) ingestion has been reported to reduce thermal strain during cycling in the heat. In this study, nine active participants ingested 20 mg of ACT per kg of total body mass (ACT) or a placebo (PLA), 60 min prior to cycling at a fixed rate of metabolic heat production (ACT: 8.3 ± 0.3 W/kg; PLA: 8.5 ± 0.5 W/kg), which was equivalent to 55 ± 6% VO2max , for 60 min at 34.5 ± 0.1 °C, 52 ± 1% relative humidity. Resting rectal temperature (Tre ; ACT: 36.70 ± 0.17 °C; PLA: 36.80 ± 0.16 °C, P = 0.24), esophageal temperature (Tes ; ACT: 36.54 ± 0.22 °C; PLA: 36.61 ± 0.17 °C, P = 0.50) and mean skin temperature (Tsk ; ACT: 34.00 ± 0.14 °C; PLA: 33.96 ± 0.20 °C, P = 0.70) were all similar among conditions. At end-exercise, no differences in ΔTre (ACT: 1.12 ± 0.15 °C; PLA: 1.11 ± 0.21 °C, P = 0.92), ΔTes (ACT: 0.90 ± 0.28 °C; PLA: 0.88 ± 0.23 °C, P = 0.84), ΔTsk (ACT: 0.80 ± 0.39 °C; PLA: 0.70 ± 0.46 °C, P = 0.63), mean local sweat rate (ACT: 1.02 ± 0.15 mg/cm(2) /min; PLA: 1.02 ± 0.13 mg/cm(2) /min, P = 0.98) and whole-body sweat loss (ACT: 663 ± 83 g; PLA: 663 ± 77 g, P = 0.995) were evident. Furthermore, ratings of perceived exertion and thermal sensation and thermal comfort were not different between ACT and PLA conditions. In conclusion, ACT ingested 60 min prior to moderate intensity exercise in hot-humid conditions does not alter physiologic thermoregulatory control nor perceived strain.

摘要

据报道,急性摄入对乙酰氨基酚(ACT)可减轻在热环境中骑行时的热应激。在本研究中,九名活跃参与者在以固定代谢产热率(ACT组:8.3±0.3W/kg;安慰剂组:8.5±0.5W/kg,相当于55±6%的最大摄氧量)骑行前60分钟,每千克总体重摄入20mg的ACT或安慰剂(PLA),在34.5±0.1°C、相对湿度52±1%的环境下骑行60分钟。静息直肠温度(Tre;ACT组:36.70±0.17°C;安慰剂组:36.80±0.16°C,P = 0.24)、食管温度(Tes;ACT组:36.54±0.22°C;安慰剂组:36.61±0.17°C,P = 0.50)和平均皮肤温度(Tsk;ACT组:34.00±0.14°C;安慰剂组:33.96±0.20°C,P = 0.70)在各条件下均相似。运动结束时,Tre的变化量(ACT组:1.12±0.15°C;安慰剂组:1.11±0.21°C,P = 0.92)、Tes的变化量(ACT组:0.90±0.28°C;安慰剂组:0.88±0.23°C,P = 0.84)、Tsk的变化量(ACT组:0.80±0.39°C;安慰剂组:0.70±0.46°C,P = 0.63)、局部平均出汗率(ACT组:1.02±0.15mg/cm²/min;安慰剂组:1.02±0.13mg/cm²/min,P = 0.98)和全身出汗量(ACT组:663±83g;安慰剂组:663±77g,P = 0.995)均无明显差异。此外,在ACT组和安慰剂组条件下,主观用力感觉、热感觉和热舒适度评分也没有差异。总之,在湿热条件下进行中等强度运动前60分钟摄入ACT不会改变生理体温调节控制,也不会改变主观感觉的应激程度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验